期刊文献+

难治性慢性鼻-鼻窦炎与细菌生物膜 被引量:5

Refractory chronic rhinosinusitis and bacterial biofilm
原文传递
导出
摘要 慢性鼻-鼻窦炎(CRS)是鼻腔和鼻窦黏膜的慢性炎症,症状持续至少12周,是宿主和环境多因素相互作用的结果。CRS是耳鼻咽喉科的常见疾病,最近有报道指出美国CRS患病率大于16%, Summary Chronic rhinosinusitis(CRS) is a common disease in otolaryngology, and with the development of the therapy technology, most of the cases have reached a cure. But there are still some intractable cases in clinic, signs and symptoms of chronic rhinosinusitis of which still persist after the standardized drugs and technically adequate endoscopic sinus surgery, and this part is clinically named refractory chronic rhinosinusitis(RCRS). In re cent studies of the pathogenesis of RCRS, bacterial biofilm(BBF) is attracting more attention. The main emphasis of this review will be to highlight the biological characteristics of BBF, the relationship of BBF and CRS and treatment strategies of BBF positive CRS.
出处 《临床耳鼻咽喉头颈外科杂志》 CAS 北大核心 2013年第20期1160-1162,共3页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
基金 卫生部行业科研专项科研基金资助项目(No:201202005)
关键词 鼻窦炎 细菌生物膜 sinusitis bacterial biofilm
  • 相关文献

参考文献27

  • 1T1EU D D, KERN R C, SCHLEIMER R P. Altera- tions in epithelial barrier function and host defense re- sponses in chronic rhinosinusitis[J]. J Allergy Clin Immunol, 2009,124 : 37 -- 42.
  • 2LEE S, LANE A P. Chronic rhinosinusitis as a mul tifactorial inflammatory disorder[J]. Curr Infect Dis Rep,2011,13:159--168.
  • 3DESROSIERS M. Refractory chronic rhinosinusitis pa'hophysiology and management o{ chronic rhinosinusitis persisling after endoscopic sinus surgery[J]. (2urr Allergy Asthma Rep, 2004,4 : 200-- 207.
  • 4YOU H, ZHUGE P, LI 1), et bacterial biofilm expression in al. chronic affecting and the influences on prognosis[J]. Am J Otolaryn gol,2011,32..583 590.
  • 5MACASSEY E, DAWES P. Biofilms and their role in otorhinolaryngological disease [ J ]. J I.aryngol Otol, 2008,122 .. 1273 - 1278.
  • 6HAI.I.-ST()ODI.EY L, COSTERTON J W, STOOD LEY P. Bamerial biofilms: from the natural environment to infectious diseases[J]. Nat Rev Microbiol, 2004,2: 95 108.
  • 7STEWART P S, COSTERTON J W. Antibiotic re- sistance of bacteria in biofilms[J]. I.ancet,2001,358 135--138.
  • 8WAI.TERS M R, ROE F, BUGNICOURT A, et al. Contributions of antibiotic penetration, oxygen limi ration, and low metabolic activity to tolerance o[ Pseudomonas aeruginosa biofims to ciprof[oxacin and tobramycin[J]. Antimierob Agents Chemother,2003, 47:317--323.
  • 9FUX C A, WII.SON S, STO()DLEY P. Detachment characteristics and oxacillin resistance of Staphylocco- cus aureus biofilm emboli in an in vitro catheter infec- tion model[J]. J Bacteriol,2004,186:4486--4491.
  • 10JEFFERSON K K, GOLDMANN D A, PIER G B. Use of confocal microscopy to analyze the rate of van- comycin penetration through Staphylococcus aureus biofilms[J]. Antimicrob Agents Chemother, 2005, 49:2467 2473.

二级参考文献84

  • 1Fokkens W, Lund V, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps 2007. Rhinology Suppl, 2007: 1-136.
  • 2Bhattacharyya N. Bacterial infection in chronic rhinosinusitis: a controlled paired analysis. Am J Rhinology, 2005, 19: 544-548.
  • 3Wallwork B, Coman W, Mackay-Sim A, et al. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoacope, 2006, 116 : 189-193.
  • 4Hashiba M, Baba S. Efficacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis. Acta Otolaryngol Suppl, 1996,525:73-78.
  • 5Ichimura K, Shimazaki Y, Ishibashi T, et al. Effect of new macrolide roxithromycin upon nasal polyps associated with chronic sinusitis. Auris Nasus Larynx, 1996,23:48-56.
  • 6Gandhi A, Brodsky L, Ballow M. Benefits of antibiotic prophylaxis in children with chronic sinusitis: assessment of outcome predictors. Allergy Proc, 1993,14:37-43.
  • 7Cervin A. The anti-inflamatory effect of erythromycin and its derivatives, with special reference to nasal polyposis and chronic sinusitis. Acta Otolaryngol, 2001,121:83-92.
  • 8Wallwork B, Coman W, Mackay-Sire A, et al. Effect of clarithromycin on nuclear factor-kappa B and transforming growth factor-beta in chronic rhinosinusitis. Laryngoscope, 2004, 114 : 286-290.
  • 9Kikuchi T, Hagiwara K, Honda Y, et al. Clarithromycin suppresses lipopolysaccharide- induced interleukin-8 production by human monocytes through AP-1 and NF-κB transcription factors. J Antimicrob Chemother, 2002, 49 : 745-755.
  • 10Kohyama T, Takizawa S, Kawasaki S, et al. Forteen-member macrolides inhibit interleukin-8 release by human eosinophils from atoptic donors. Antimicrob Agents Chemother, 1999, 43: 907-911.

共引文献76

同被引文献28

引证文献5

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部